Drug Shortage Report for NEVANAC
| Report ID | 79161 |
| Drug Identification Number | 02308983 |
| Brand name | NEVANAC |
| Common or Proper name | NEVANAC SUSP 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NEPAFENAC |
| Strength(s) | 0.1% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BC |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2019-03-25 |
| Actual start date | 2019-03-25 |
| Estimated end date | 2019-04-16 |
| Actual end date | 2019-04-17 |
| Shortage status | Resolved |
| Updated date | 2019-04-18 |
| Company comments | Potential nepafenac treatment alternatives available: ILEVRO |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2019-04-18 | English | Compare |
| v9 | 2019-04-17 | French | Compare |
| v8 | 2019-04-17 | English | Compare |
| v7 | 2019-04-05 | French | Compare |
| v6 | 2019-04-05 | English | Compare |
| v5 | 2019-03-26 | French | Compare |
| v4 | 2019-03-26 | English | Compare |
| v3 | 2019-03-26 | English | Compare |
| v2 | 2019-03-21 | French | Compare |
| v1 | 2019-03-21 | English | Compare |
Showing 1 to 10 of 10